252
Y.-N. Yan et al. / Dyes and Pigments 86 (2010) 249e258
2.2.3.3. 4-(1-n-Butylphenanthroimidazol-2-yl)benzohydrazide (3c).
White solid, yield 80%; m.p. 223e224 ꢀC. 1H NMR (300 MHz, DMSO-
1H NMR (300 MHz, CDCl3):
d
0.64 (t, J ¼ 7.5 Hz, 3H, CH3), 0.98e1.05
(m, 2H, CH2), 1.32e1.43 (m, 2H, CH2), 3.96 (t, J ¼ 6.9 Hz, 2H, NCH2),
7.10e7.24 (m, 4H, ArH), 7.42e7.55 (m, 9H, ArH), 7.92 (d, J ¼ 8.1 Hz,
2H, ArH), 8.11e8.20 (m, 2H, ArH), 8.27 (d, J ¼ 7.2 Hz, 2H, ArH). 13C
d6):
d
0.69 (t, J ¼ 7.2 Hz, 3H, CH3), 1.03e1.18 (m, 2H, CH2), 1.73e1.87
(m, 2H, CH2), 4.57 (t, J ¼ 7.5 Hz, 2H, NCH2), 4.69 (br, 2H, NH2),
7.58e7.81 (m, 4H, ArH), 7.87 (d, J ¼ 6.9 Hz, 2H, ArH), 8.06 (d,
J ¼ 7.8 Hz, 2H, ArH), 8.33e8.44 (m, 1H, ArH), 8.59 (d, J ¼ 7.5 Hz, 1H,
ArH), 8.77e8.88 (m, 1H, ArH), 8.89e9.00 (m, 1H, ArH), 9.96 (s, 1H,
CONH). ESI-MS (m/z): 409 [M þ H]þ.
NMR (75 MHz, CDCl3):
d 13.4, 19.6, 32.7, 44.8, 123.8, 126.3, 126.7,
126.9, 127.0, 127.9, 128.7, 128.9, 129.4, 130.4, 130.9, 131.1, 131.7, 134.2,
134.6, 138.2, 146.1, 164.1, 164.6. HRMS (EI) (Mþ): Calcd. for
C33H28N4O: 496.2263; found: 496.2258. Anal. Calcd. (%) for
C33H28N4O: C, 79.81; H, 5.68; N, 11.28. Found: C, 79.61; H, 5.87; N,
11.33.
2.2.4. General procedure for the synthesis of 4aei
The benzohydrazide derivative (2 mmol) was added to a stirred
solution of the corresponding benzoyl chloride (or 2-naphthoyl
chloride, or thiophene-2-carbonyl chloride) (2 mmol) in anhydrous
pyridine (10 mL). The mixture was refluxed for 20e24 h, cooled and
washed with water and the ensuing crude product was filtered,
dried and then was added to phosphorus oxychloride (caution:
reacts violently with water; incompatible with many metals, alco-
hols, amines, phenol, DMSO, strong bases; 10 mL); the mixture was
refluxed overnight. The majority of phosphorus oxychloride was
distilled from the reaction mixture and the residue was gently
added to powdered ice. The resulting oxadiazole product was
filtered, washed with water, dried and recrystallized from the
mixture of chloroform and ethanol, or purified by silica-gel column
chromatography using petroleum (b.p. 60e90 ꢀC)/ethyl acetate
(2:1) as eluent.
2.2.4.5. 2-(4-(1-n-Butyl-4,5-diphenylimidazol-2-yl)phenyl)-5-
(naphthalen-2-yl)-1,3,4-oxadiazole (4e). White solid, yield 44%; m.
p. 206e208 ꢀC. 1H NMR (300 MHz, DMSO-d6):
d
0.57 (t, J ¼ 7.2 Hz,
3H, CH3), 0.90e1.02 (m, 2H, CH2), 1.28e1.38 (m, 2H, CH2), 4.01 (t,
J ¼ 7.5 Hz, 2H, NCH2), 7.11e7.24 (m, 3H, ArH), 7.41e7.60 (m, 7H,
ArH), 7.60e7.72 (m, 2H, ArH), 8.02e8.07 (m, 3H, ArH), 8.15e8.24
(m, 3H, ArH), 8.36 (d, J ¼ 8.7 Hz, 2H, ArH), 8.82 (s, 1H, ArH). 13C NMR
(75 MHz, CDCl3):
d 13.4, 19.6, 32.7, 44.8, 121.0, 123.2, 123.8, 126.3,
126.7, 127.0,127.1, 127.3,127.8, 127.9, 128.0, 128.7,128.8, 129.0, 129.5,
130.5, 130.9, 131.1, 132.8, 134.2, 134.6, 138.3, 146.1, 164.2, 164.8. ESI-
MS (m/z): 547 [M þ H]þ. Anal. Calcd. (%) for C37H30N4O$0.2H2O: C,
80.76; H, 5.57; N, 10.18. Found: C, 80.77; H, 5.59; N, 10.21.
2.2.4.6. 2-(4-(1-n-Butyl-4,5-diphenylimidazol-2-yl)phenyl)-5-(thi-
ophen-2-yl)-1,3,4-oxadiazole (4f). Yellowish solid, yield 41%; m.p.
2.2.4.1. 2-(4-(1-n-Butylbenzimidazol-2-yl)phenyl)-5-phenyl-1,3,4-
oxadiazole (4a). White solid, yield 50%; m.p. 144e146 ꢀC. 1H NMR
168e169 ꢀC. 1H NMR (300 MHz, CDCl3):
d
0.60 (t, J ¼ 6.9 Hz, 3H,
CH3), 0.90e1.06 (m, 2H, CH2), 1.23e1.40 (m, 2H, CH2), 4.09 (t,
J ¼ 7.2 Hz, 2H, NCH2), 7.14e7.32 (m, 4H, ArH), 7.33e7.48 (m, 4H,
ArH), 7.49e7.62 (m, 4H, ArH), 7.85 (s, 1H, ArH), 8.01 (d, J ¼ 7.2 Hz,
2H, ArH), 8.28 (d, J ¼ 7.2 Hz, 2H, ArH). 13C NMR (75 MHz, CDCl3):
(300 MHz, DMSO-d6):
d
0.77 (t, J ¼ 7.2 Hz, 3H, CH3), 1.11e1.23 (m,
2H, CH2), 1.64e1.74 (m, 2H, CH2), 4.38 (t, J ¼ 6.9 Hz, 2H, NCH2),
7.24e7.34 (m, 2H, ArH), 7.64e7.73 (m, 5H, ArH), 8.06 (d, J ¼ 8.1 Hz,
2H, ArH), 8.17 (d, J ¼ 7.5 Hz, 2H, ArH), 8.33 (d, J ¼ 8.1 Hz, 2H, ArH).
d
13.3, 19.5, 32.6, 44.8, 123.5, 124.9, 126.3, 126.7, 127.0, 127.9, 128.1,
13C NMR (75 MHz, DMSO-d6):
d
13.3, 19.2, 31.2, 43.9, 110.9, 119.1,
128.7, 128.9, 129.4, 129.8, 130.2, 130.4, 130.8, 131.0, 134.2, 134.6,
138.2, 146.0, 160.8, 163.5. ESI-MS (m/z): 503 [M þ H]þ. Anal. Calcd.
(%) for C31H26N4OS: C, 74.08; H,5.21; N, 11.15. Found: C, 73.83; H,
5.27; N, 11.19.
122.0, 122.6, 123.1, 123.9, 126.6, 126.8, 129.2, 129.8, 131.9, 133.4,
135.6, 142.2, 151.3, 163.3, 163.9. ESI-MS (m/z): 395 [M þ H]þ. Anal.
Calcd. (%) for C25H22N4O$1.5H2O: C, 71.24; H, 5.98; N, 13.29. Found:
C, 71.40; H, 5.80; N, 13.39.
2.2.4.7. 2-(4-(1-n-Butylphenanthroimidazol-2-yl)phenyl)-5-phenyl-1,
2.2.4.2. 2-(4-(1-n-Butylbenzimidazol-2-yl)phenyl)-5-(naphthalen-2-
3,4-oxadiazole (4g). Yellowish solid, yield 40%; m.p. 209e210 ꢀC. 1H
yl)-1,3,4-oxadiazole (4b). White solid, yield 46%; m.p. 216e218 ꢀC.
NMR (300 MHz, CDCl3):
d
0.85 (t, J ¼ 6.6 Hz, 3H, CH3), 1.19e1.36 (m,
1H NMR (300 MHz, DMSO-d6):
d
0.79 (t, J ¼ 7.2 Hz, 3H, CH3),
2H, CH2), 1.90e2.07 (m, 2H, CH2), 4.70 (t, J ¼ 6.9 Hz, 2H, NCH2),
7.51e7.61 (m, 3H, ArH), 7.61e7.77 (m, 4H, ArH), 7.99 (d, J ¼ 7.8 Hz,
2H, ArH), 8.12e8.30 (m, 3H, ArH), 8.37 (d, J ¼ 7.8 Hz, 2H, ArH), 8.72
(d, J ¼ 8.1 Hz, 1H, ArH), 8.76e8.91 (m, 2H, ArH). 13C NMR (75 MHz,
1.13e1.25 (m, 2H, CH2), 1.66e1.75 (m, 2H, CH2), 4.39 (t, J ¼ 7.2 Hz,
2H, NCH2), 7.25e7.35 (m, 2H, ArH), 7.65e7.73 (m, 5H, ArH),
8.03e8.08 (m, 3H, ArH), 8.14e8.23 (m, 3H, ArH), 8.38 (d, J ¼ 8.1 Hz,
2H, ArH), 8.80 (s, 1H, ArH). 13C NMR (75 MHz, CDCl3):
d
13.6, 20.0,
CDCl3): d 13.5, 19.6, 29.7, 46.9, 120.6,122.4, 122.9, 123.2, 123.6, 124.3,
31.9, 44.7, 110.1, 120.0, 120.8, 122.5, 123.0, 123.1, 124.7, 127.0, 127.1,
127.3, 127.8, 127.9, 128.7, 128.9, 129.8, 132.7, 133.7, 134.6, 135.6,
142.9, 152.0, 163.9, 164.8. ESI-MS (m/z): 445 [M þ H]þ. Anal. Calcd.
(%) for C29H24N4O$0.4H2O: C, 77.11; H, 5.53; N, 12.40. Found: C,
77.03; H, 5.40; N, 12.30.
124.8,125.5,126.4,126.7,126.8,126.9,127.1,127.2,128.1,128.9,129.1,
130.5, 131.7, 134.0, 138.1, 151.1, 163.8, 164.6. HRMS (EI) (Mþ): Calcd.
for C33H26N4O: 494.2107; found: 494.2102. Anal. Calcd. (%) for
C33H26N4O$0.5H2O: C, 78.99; H, 5.38; N, 11.17. Found: C, 78.93; H,
6.06; N, 10.98.
2.2.4.3. 2-(4-(1-n-Butylbenzimidazol-2-yl)phenyl)-5-(thiophen-2-yl)-
2.2.4.8. 2-(4-(1-n-Butylphenanthroimidazol-2-yl)phenyl)-5-(naph-
thalen-2-yl)-1,3,4-oxadiazole (4h). Yellowish solid, yield 34%; m.p.
1,3,4-oxadiazole (4c). White solid, yield 45%; m.p. 111e112 ꢀC. 1H
NMR (300 MHz, DMSO-d6):
d
0.77 (t, J ¼ 7.2 Hz, 3H, CH3), 1.10e1.23
259e260 ꢀC. 1H NMR (300 MHz, CDCl3):
d
0.86 (t, J ¼ 7.2 Hz, 3H,
(m, 2H, CH2), 1.64e1.73 (m, 2H, CH2), 4.38 (t, J ¼ 7.2 Hz, 2H, NCH2),
7.23e7.36 (m, 3H, ArH), 7.70 (t, J ¼ 7.2 Hz, 2H, ArH), 7.99e8.01 (m,
2H, ArH), 8.05 (d, J ¼ 8.7 Hz, 2H, ArH), 8.28 (d, J ¼ 8.7 Hz, 2H, ArH).
CH3), 1.23e1.35 (m, 2H, CH2), 1.90e2.03 (m, 2H, CH2), 4.69 (t,
J ¼ 7.2 Hz, 2H, NCH2), 7.58e7.75 (m, 6H, ArH), 7.91e7.94 (m, 1H,
ArH), 7.99 (t, J ¼ 9.0 Hz, 4H, ArH), 8.27 (t, J ¼ 8.7 Hz, 2H, ArH),
8.40 (d, J ¼ 8.1 Hz, 2H, ArH), 8.67e8.72 (m, 2H, ArH), 8.81 (d,
J ¼ 7.2 Hz, 1H, ArH), 8.86 (d, J ¼ 7.8 Hz, 1H, ArH). 13C NMR
13C NMR (75 MHz, DMSO-d6):
d 13.3, 19.2, 31.3, 43.9, 110.9, 119.2,
122.0, 122.6, 122.7, 123.7, 124.0, 126.8, 128.6, 129.9, 130.6, 131.7,
133.4, 135.6, 142.3, 151.4, 160.4, 162.8. ESI-MS (m/z): 401 [M þ H]þ.
Anal. Calcd. (%) for C23H20N4OS$1$1H2O: C, 65.72; H, 5.32; N, 13.33.
Found: C, 65.50; H, 5.25; N, 13.29.
(75 MHz, CDCl3):
d 13.2, 19.3, 30.9, 48.9, 120.2, 120.6, 121.9, 122.2,
122.6, 123.9, 124.2, 124.3, 124.8, 126.7, 126.8, 126.9, 126.9, 126.9,
127.1, 127.6, 127.7, 127.8, 128.3, 128.7, 129.6, 132.1, 132.4, 134.5,
146.5, 162.7, 164.7. ESI-MS (m/z): 545 [M þ H]þ. Anal. Calcd. (%)
for C37H28N4O$0.7H2O: C, 79.75; H, 5.32; N, 10.05. Found: C,
79.72; H, 5.42; N 9.72.
2.2.4.4. 2-(4-(1-n-Butyl-4,5-diphenylimidazol-2-yl)phenyl)-5-phenyl-
1,3,4-oxadiazole (4d). Yellowish solid, yield 45%; m.p. 147e148 ꢀC.